Nasreen C. Jahed

1.5k total citations · 1 hit paper
10 papers, 1.1k citations indexed

About

Nasreen C. Jahed is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Nasreen C. Jahed has authored 10 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 8 papers in Virology and 6 papers in Emergency Medicine. Recurrent topics in Nasreen C. Jahed's work include HIV Research and Treatment (8 papers), HIV/AIDS drug development and treatment (7 papers) and HIV-related health complications and treatments (6 papers). Nasreen C. Jahed is often cited by papers focused on HIV Research and Treatment (8 papers), HIV/AIDS drug development and treatment (7 papers) and HIV-related health complications and treatments (6 papers). Nasreen C. Jahed collaborates with scholars based in United States, United Kingdom and Egypt. Nasreen C. Jahed's co-authors include Eric S. Daar, Paul E. Sax, Camlin Tierney, Belinda Ha, Laurie Myers, Douglas Kitch, Grace A. McComsey, Pablo Tebas, Kathleen Melbourne and David Katzenstein and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Nasreen C. Jahed

10 papers receiving 1.1k citations

Hit Papers

Bone Mineral Density and Fractures in Antiretroviral-Naiv... 2011 2026 2016 2021 2011 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202
    2011 381 citations Grace A. McComsey, Douglas Kitch et al. The Journal of Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nasreen C. Jahed United States 10 812 753 598 184 145 10 1.1k
Laurie Myers United States 8 656 0.8× 533 0.7× 454 0.8× 164 0.9× 123 0.8× 8 899
Patrizia Zucchi Italy 7 295 0.4× 270 0.4× 138 0.2× 137 0.7× 151 1.0× 15 498
Marisa Tungsiripat United States 11 306 0.4× 449 0.6× 247 0.4× 15 0.1× 96 0.7× 14 576
Eric Billaud France 12 185 0.2× 152 0.2× 115 0.2× 45 0.2× 182 1.3× 28 488
Ei Kinai Japan 12 352 0.4× 241 0.3× 137 0.2× 23 0.1× 122 0.8× 39 473
Jorge Benetucci Argentina 15 417 0.5× 183 0.2× 354 0.6× 12 0.1× 184 1.3× 35 646
Anna Danise Italy 13 382 0.5× 104 0.1× 289 0.5× 22 0.1× 128 0.9× 24 504
Monica Guffanti Italy 11 206 0.3× 158 0.2× 143 0.2× 22 0.1× 82 0.6× 28 349
M Mannazzu Italy 9 155 0.2× 197 0.3× 83 0.1× 58 0.3× 97 0.7× 14 385
José Mallolas Spain 7 469 0.6× 295 0.4× 275 0.5× 11 0.1× 340 2.3× 9 771

Countries citing papers authored by Nasreen C. Jahed

Since Specialization
Citations

This map shows the geographic impact of Nasreen C. Jahed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nasreen C. Jahed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nasreen C. Jahed more than expected).

Fields of papers citing papers by Nasreen C. Jahed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nasreen C. Jahed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nasreen C. Jahed. The network helps show where Nasreen C. Jahed may publish in the future.

Co-authorship network of co-authors of Nasreen C. Jahed

This figure shows the co-authorship network connecting the top 25 collaborators of Nasreen C. Jahed. A scholar is included among the top collaborators of Nasreen C. Jahed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nasreen C. Jahed. Nasreen C. Jahed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
McComsey, Grace A., Douglas Kitch, Paul E. Sax, et al.. (2013). Associations of Inflammatory Markers With AIDS and Non-AIDS Clinical Events After Initiation of Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 65(2). 167–174. 52 indexed citations
2.
Erlandson, Kristine M., Douglas Kitch, Camlin Tierney, et al.. (2013). Weight and lean body mass change with antiretroviral initiation and impact on bone mineral density. AIDS. 27(13). 2069–2079. 37 indexed citations
3.
McComsey, Grace A., Douglas Kitch, Eric S. Daar, et al.. (2012). Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir. AIDS. 26(11). 1371–1385. 78 indexed citations
4.
McComsey, Grace A., Douglas Kitch, Eric S. Daar, et al.. (2011). Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202. The Journal of Infectious Diseases. 203(12). 1791–1801. 381 indexed citations breakdown →
5.
Sax, Paul E., Camlin Tierney, Ann C. Collier, et al.. (2011). Abacavir/Lamivudine Versus Tenofovir DF/Emtricitabine as Part of Combination Regimens for Initial Treatment of HIV: Final Results. The Journal of Infectious Diseases. 204(8). 1191–1201. 130 indexed citations
6.
McComsey, Grace A., Douglas Kitch, Paul E. Sax, et al.. (2011). Peripheral and Central Fat Changes in Subjects Randomized to Abacavir-Lamivudine or Tenofovir-Emtricitabine With Atazanavir-Ritonavir or Efavirenz: ACTG Study A5224s. Clinical Infectious Diseases. 53(2). 185–196. 94 indexed citations
7.
Sax, Paul E., Camlin Tierney, Ann C. Collier, et al.. (2009). Abacavir–Lamivudine versus Tenofovir–Emtricitabine for Initial HIV-1 Therapy. New England Journal of Medicine. 361(23). 2230–2240. 215 indexed citations
8.
Tebas, Pablo, Roy M. Matining, John L. Schmitz, et al.. (2008). Metabolic and Immune Activation Effects of Treatment Interruption in Chronic HIV-1 Infection: Implications for Cardiovascular Risk. PLoS ONE. 3(4). e2021–e2021. 53 indexed citations
9.
Skiest, Daniel J., Zhaohui Su, Diane V. Havlir, et al.. (2007). Interruption of Antiretroviral Treatment in HIV‐Infected Patients with Preserved Immune Function Is Associated with a Low Rate of Clinical Progression: A Prospective Study by AIDS Clinical Trials Group 5170. The Journal of Infectious Diseases. 195(10). 1426–1436. 51 indexed citations
10.
Henry, Keith, David Katzenstein, Hernán Valdez, et al.. (2006). A Pilot Study Evaluating Time to CD4 T-cell Count <350 cells/mm3 After Treatment Interruption Following Antiretroviral Therapy ± Interleukin 2: Results of ACTG A5102. JAIDS Journal of Acquired Immune Deficiency Syndromes. 42(2). 140–148. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laurie Myers Breakdown of academic impact, for papers by Patrizia Zucchi Breakdown of academic impact, for papers by Marisa Tungsiripat Breakdown of academic impact, for papers by Eric Billaud Breakdown of academic impact, for papers by Ei Kinai Breakdown of academic impact, for papers by Jorge Benetucci Breakdown of academic impact, for papers by Anna Danise Breakdown of academic impact, for papers by Monica Guffanti Breakdown of academic impact, for papers by M Mannazzu Breakdown of academic impact, for papers by José Mallolas
Rankless by CCL
2026